Search Contract Opportunities

Pharmaceutical Prime Vendor Global GEN V Solicitation   5

ID: SPE2DX-24-R-0001_SOLICITATION • Type: Solicitation • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
Does this solicitation list any subcontracting requirements?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Pharmaceutical Prime Vendor Generation V (PPV-G GEN V) Solicitation SPE2DX-24-R-0001. See attachments.

Background
The solicitation is for the Pharmaceutical Prime Vendor Generation V (PPV-G GEN V) and is related to protecting controlled unclassified information (CUI). The document provides detailed security requirements and controls for nonfederal systems or organizations when mandated by a federal agency in a contract, grant, or other agreement. It also includes a framework for improving critical infrastructure cybersecurity.

Work Details
The solicitation outlines specific security requirements and controls for protecting CUI, including access control, awareness and training, audit and accountability, security assessment and authorization, and configuration management. It also provides references to laws, executive orders, regulations, instructions, standards, and guidelines related to information security.

Overview

Response Deadline
July 8, 2024, 3:00 p.m. EDT (original: April 29, 2024, 3:00 p.m. EDT) Past Due
Posted
March 13, 2024, 11:08 a.m. EDT (updated: June 6, 2024, 8:48 a.m. EDT)
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
Est. Value Range
Experimental
$1,000,000 - $5,000,000 (AI estimate)
On 3/13/24 DLA Troop Support - Medical issued Solicitation SPE2DX-24-R-0001_SOLICITATION for Pharmaceutical Prime Vendor Global GEN V Solicitation due 7/8/24. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
CATHERINE GILBERT   Profile
Phone
(215) 737-4778

Secondary Contact

Name
Lorinda Ferraiolo   Profile
Phone
(215) 737-7014

Documents

Posted documents for Solicitation SPE2DX-24-R-0001_SOLICITATION

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2DX-24-R-0001_SOLICITATION

Award Notifications

Agency published notification of awards for Solicitation SPE2DX-24-R-0001_SOLICITATION

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2DX-24-R-0001_SOLICITATION

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2DX-24-R-0001_SOLICITATION

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2DX
Source Organization Code
500040903
Last Updated
June 6, 2024
Last Updated By
catherine.gilbert@dla.mil
Archive Date
April 30, 2034